Approach to Type 2 Respiratory Failure Changing Nature of NIV

Total Page:16

File Type:pdf, Size:1020Kb

Approach to Type 2 Respiratory Failure Changing Nature of NIV Approach to type 2 Respiratory Failure Changing Nature of NIV • Not longer just the traditional COPD patients • Increasingly – Obesity – Neuromuscular – Pneumonias • 3 fold increase in patients with Ph 7.25 and below Impact • Changing guidelines • Increased complexity • Increased number of patients • Decreased threshold for initiation • Lower capacity for ITU to help • Higher demands on nursing staff Resp Failure • Type 1 Failure of Oxygenation • Type 2 Failure of Ventilation • Hypoventilation • Po2 <8 • Pco2 >6 • PH low or bicarbonate high Ventilation • Adequate Ventilation – Breathe in deeply enough to hit a certain volume – Breathe out leaving a reasonable residual volume – Breath quick enough – Tidal volume and minute ventilation Response to demand • Increase depth of respiration • Use Reserve volume • Increase rate of breathing • General increase in minute ventilation • More gas exchange Failure to match demand • Hypoventilation • Multifactorial • Can't breathe to a high enough volume • Can't breath quick enough • Pco2 rises • Po2 falls Those at risk • COPD • Thoracic restriction • Central • Neuromuscular • Acute aspects – Over oxygenation – Pulmonary oedema Exhaustion • Complicates all forms of resp failure • Type one will become type two • Needs urgent action • Excessive demand • Unable to keep up • Resp muscle hypoxia Exhaustion • Muscles weaken • Depth of inspiration drops • Residual volume drops • Work to breath becomes harder • Spiral of exhaustion • Pco2 rises, Po2 drops Type 2 Respiratory Failure Management Identifying Those at Risk • Pre-existing conditions • Acute factors – Bronchoconstriction/Pulmonary oedema – Hypoxia • Superimposed problems – Metabolic acidosis – Low cardiac output Recognising the problem • Pick them up early- plan escalation • Confusion • Flap • Signs of exhaustion • Agitation, • High HR, • High BP • Sweaty Why are they in type two? • Don’t assume • Multifactorial • Examination- wheeze, opiods, oedema • EARLY x-ray- Pneumothorax • ECG- Myocardial infarction • Bloods- Metabolic, BM, TSH Simple Measures • Reduce work of breathing • Sit them up- 45 degree angle • Good sputum clearance • Enough oxygen- 88-92%? hypoxia will kill you first • Avoid resp depressants • Max cardiac output Treat underlying cause • Bronchospasm – Reduces air trapping and V/Q mismatch – Lots of nebs, magnesium, aminophyline • Pleural disease – drain pneumothorax/effusions • Cardiac output – fluids/inotropes Non Invasive Ventilation • Augmenting patients breathing without an ET tube • Maximises Inspiratory volume (maintains tidal volume) • Stops airway collapse • Can control rate of breathing • Reduces the work of breathing NIV • Bilevel positive pressure ventilation • Maintaining the volume in the lungs between two ideal levels • Applies pressure at maximum ventilation (ipap) • Applies pressure at maximum expiration to splint airways (epap) NIV- Does it work • Up to 70% reduction in work of breathing • Improved mortality over invasive ventilation • Reduced – Invasive ventilation – Hospital mortality – Length of stay • Mortality static over 10 years • Effective in the elderly Role of NIV • Support tiring patient at early stage • Treat type two resp failure to avoid invasive ventilation • Ceiling of treatment when invasive ventilation is inappropriate • Palliation Timing of NIV • Is the PH <7.35 • Is the Pco2 >6.5 (i.e. do they have a respiratory acidosis) • Is their oxygen appropriate for the patient? • Have you treated the correctable factors for 30-60mins? • If so consider starting NIV Timing of NIV • Maximise for an hour? – Mild to Moderate Acidosis – COPD – 20% will improve • Delay of more than hour is harmful • Delay in other patient groups – Poorer outcomes Timing of NIV • Maximise one hour if – Simple copd exacerbation – Ph 7.25 or above – Capacity for review in one hour – Capacity for immediate initiation of NIV – No signs of exhaustion Contra indications to NIV • Very few – No longer • Low ph • Low GCS • Mainly indications for Invasive ventilation • Facial injuries • Poor upper airway • Uncontrolled bowel obstruction- NG tube Who should be invasively ventilated • 1) Reversible pathology • 2) Remains active • 3) Reasonable muscle bulk And don’t forget • 4) Patients wishes • Contact early!! Decision Time • Is this patient more appropriate for consideration for immediate invasive ventilation? • Poor upper airway • very hypoxic • severe sepsis • bowel obstruction • Not PH or decreased GCS Decision Time • Is the patient suitable for NIV but should be considered for ITU if fails NIV? – Protect respiratory muscles – Prevent VAP – Protect against muscle wasting – Protect against ITU Psychosis – Patients do better on NIV NIV as a Trial • Best done in ITU – Ph < 7.15 – Decreased GCS – Confusion – Pneumonia • Delayed intubation = increased mortality • Make decisions early and be proactive Special Circumstances • Pulmonary Oedema – Works – May not keep them alive long term • Asthma – Just don't • Pneumonia – If not for ITU Where to NIV? • Initiation shouldn’t be delayed • Specialist Unit • Appropriate staffing – Trained Nurses – Capacity to do regular obs – 2-1 nursing – Level 2-3 Setting up • Mode – Bilevel/bipap/pressure support • Ipap – High pressure used to fill the lung • Epap – Low pressure use to keep lungs open • Difference Ipap and Epap = Tidal volume IPAP Vs EPAP • IPAP controls depth of ventilation • Bigger gap between ipap and epap = deeper ventilation • Therefore IPAP controls PCO2 • EPAP overcomes stiff and noncompliant lungs and airways • EPAP and help oxygenation Rule of thumb • Initial settings • Start IPAP -15 EPAP – 3 • Review patient clinically. Is their chest rising? Is their heart rate and BP improving? Are they working less hard to breath? • If not titrate up IPAP in 2cm increments Rule of thumb • Are their sats low? • Is their chest barely moving? • Is the apnoea alarm buzzing at you? • If any of yes to any of these increase both the EPAP and IPAP by 2 increments. • Once your happy repeat ABG in 1 hour Oxygen • Continue to aim 88-92% • Supply oxygen through mask or tubing • Difficult to predict how much they need • Machine looses a lot of oxygen • Patient is ventilating better • Start high and titrate down Failing on NIV • High respiratory rate, • High BP • High pulse • Agitation • Working hard to breath with accessory muscles • Sweating Pco2 not coming down • Inadequate ventilation • Assess airway • Sit patient up • Treat underlying cause • Increase IPAP • Repeat ABG Po2 Poor • Maximise ventilation • Increased inspired Oxygen • Increase EPAP and IPAP until chest rising • Treat underlying cause • Reassess for pneumothorax/mucus plugging Conclusion • Changing nature of patients • Reduce work of breathing • Early planning- ?ITU • Early initiation- ?wait until acidotic • Very few contraindications .
Recommended publications
  • Spontaneous Pneumothorax in COVID-19 Patients Treated with High-Flow Nasal Cannula Outside the ICU: a Case Series
    International Journal of Environmental Research and Public Health Case Report Spontaneous Pneumothorax in COVID-19 Patients Treated with High-Flow Nasal Cannula outside the ICU: A Case Series Magdalena Nalewajska 1, Wiktoria Feret 1 , Łukasz Wojczy ´nski 1, Wojciech Witkiewicz 2 , Magda Wi´sniewska 1 and Katarzyna Kotfis 3,* 1 Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70–111 Szczecin, Poland; [email protected] (M.N.); [email protected] (W.F.); [email protected] (Ł.W.); [email protected] (M.W.) 2 Department of Cardiology, Pomeranian Medical University, 70–111 Szczecin, Poland; [email protected] 3 Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70–111 Szczecin, Poland * Correspondence: katarzyna.kotfi[email protected] Abstract: The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic and a burden to global health at the turn of 2019 and 2020. No targeted treatment for COVID-19 infection has been identified so far, thus supportive treatment, invasive and non-invasive oxygen support, and corticosteroids remain a common therapy. High-flow nasal cannula (HFNC), a non-invasive oxygen support method, has become a prominent treatment option for respiratory failure during the SARS-CoV-2 pandemic. Citation: Nalewajska, M.; Feret, W.; HFNC reduces the anatomic dead space and increases positive end-expiratory pressure (PEEP), Wojczy´nski,Ł.; Witkiewicz, W.; allowing higher concentrations and higher flow of oxygen. Some studies suggest positive effects of Wi´sniewska,M.; Kotfis, K. HFNC on mortality and avoidance of intubation.
    [Show full text]
  • The Child with Altered Respiratory Status
    Path: K:/LWW-BOWDEN-09-0101/Application/LWW-BOWDEN-09-0101-016.3d Date: 3rd July 2009 Time: 16:31 User ID: muralir 1BlackLining Disabled CHAPTER 16 The Child With Altered Respiratory Status Do you remember the Diaz fam- Case History leave Lela, the baby sister, ily from Chapter 9, in which with Claudia’s mother, Selma, Jose has trouble taking his asthma medication, and head to the hospital. and in Chapter 4, in which Jose’s little sister, At the hospital the emergency department Lela, expresses her personality even as a new- nurse observes Jose sitting cross-legged and born? Jose is 4 years old and was diagnosed leaning forward on his hands. His mouth is with asthma this past fall, about 6 months ago. open and he is breathing hard with an easily Since that time Claudia, his mother, has audible inspiratory wheeze. He is using his noticed several factors that trigger his asthma subclavicular accessory muscles with each including getting sick, pollen, and cold air. breath. His respiratory rate is 32 breaths per One evening following a warm early-spring minute, his pulse is 112 beats per minutes, day, Jose is outside playing as the sun sets and and he is afebrile. Claudia explains that he the air cools. When he comes inside he was fine; he was outside running and playing, begins to cough. Claudia sets up his nebulizer and then came in and began coughing and and gives him a treatment of albuterol, which wheezing, and she gave him an albuterol lessens his coughing. Within an hour, Jose is treatment.
    [Show full text]
  • Chest Pain and Non-Respiratory Symptoms in Acute Asthma
    Postgrad Med J 2000;76:413–414 413 Chest pain and non-respiratory symptoms in Postgrad Med J: first published as 10.1136/pmj.76.897.413 on 1 July 2000. Downloaded from acute asthma W M Edmondstone Abstract textbooks. Occasionally the combination of The frequency and characteristics of chest dyspnoea and chest pain results in diagnostic pain and non-respiratory symptoms were confusion. This study was prompted by the investigated in patients admitted with observation that a number of patients admitted acute asthma. One hundred patients with with asthmatic chest pain had been suspected a mean admission peak flow rate of 38% of having cardiac ischaemia, pleurisy, pericardi- normal or predicted were interviewed tis, or pulmonary embolism. It had also been using a questionnaire. Chest pain oc- observed that many patients admitted with curred in 76% and was characteristically a asthma complained of a range of non- dull ache or sharp, stabbing pain in the respiratory symptoms, something which has sternal/parasternal or subcostal areas, been noted previously in children1 and in adult worsened by coughing, deep inspiration, asthmatics in outpatients.2 The aim of this or movement and improved by sitting study was to examine the frequency and char- upright. It was rated at or greater than acteristics of chest pain and other symptoms in 5/10 in severity by 67% of the patients. A patients admitted with acute asthma. wide variety of upper respiratory and sys- temic symptoms were described both Patients and methods before and during the attack. One hundred patients (66 females, mean (SD) Non-respiratory symptoms occur com- age 45.0 (19.7) years) admitted with acute monly in the prodrome before asthma asthma were studied.
    [Show full text]
  • Clinical Management of Severe Acute Respiratory Infections When Novel Coronavirus Is Suspected: What to Do and What Not to Do
    INTERIM GUIDANCE DOCUMENT Clinical management of severe acute respiratory infections when novel coronavirus is suspected: What to do and what not to do Introduction 2 Section 1. Early recognition and management 3 Section 2. Management of severe respiratory distress, hypoxemia and ARDS 6 Section 3. Management of septic shock 8 Section 4. Prevention of complications 9 References 10 Acknowledgements 12 Introduction The emergence of novel coronavirus in 2012 (see http://www.who.int/csr/disease/coronavirus_infections/en/index. html for the latest updates) has presented challenges for clinical management. Pneumonia has been the most common clinical presentation; five patients developed Acute Respira- tory Distress Syndrome (ARDS). Renal failure, pericarditis and disseminated intravascular coagulation (DIC) have also occurred. Our knowledge of the clinical features of coronavirus infection is limited and no virus-specific preven- tion or treatment (e.g. vaccine or antiviral drugs) is available. Thus, this interim guidance document aims to help clinicians with supportive management of patients who have acute respiratory failure and septic shock as a consequence of severe infection. Because other complications have been seen (renal failure, pericarditis, DIC, as above) clinicians should monitor for the development of these and other complications of severe infection and treat them according to local management guidelines. As all confirmed cases reported to date have occurred in adults, this document focuses on the care of adolescents and adults. Paediatric considerations will be added later. This document will be updated as more information becomes available and after the revised Surviving Sepsis Campaign Guidelines are published later this year (1). This document is for clinicians taking care of critically ill patients with severe acute respiratory infec- tion (SARI).
    [Show full text]
  • PALS Helpful Hints 2015 Guidelines - December 2016 Mandatory Precourse Assessment at Least 70% Pass
    PALSPALS Helpful Helpful Hints Courtesy Hints are of CourtesyKey Medical of Resources, Key Medical Inc. Resources, www.cprclassroom.com Inc. PALS Helpful Hints 2015 Guidelines - December 2016 Mandatory precourse assessment at least 70% pass. Bring proof of completion to class. The PALS exam is 50 questions. Passing score is 84% or you may miss 8 questions. All AHA exams are now open resource, so you may use your books and/or handouts for the exam. For those persons taking PALS for the first time or updating/renewing with a current card, exam remediation is permitted should you miss more than 8 questions on the exam. Viewing the PALS book ahead of time with the online resources is very helpful. The American Heart Association link is www.heart.org/eccstudent has a pre-course self- assessment, supplementary written materials and videos. The code for these online resources is in the PALS Provider manual page ii. The code is PALS15. Basic Dysrhythmia knowledge is required. The exam has at least 5 strips to interpret. The course is a series of video segments then skills. The course materials well prepare you for the exam. Basic Dysrhythmias knowledge is required in relation to asystole, ventricular fibrillation, tachycardias in general and bradycardias in general. You do not need to know the ins and outs of each and every one. Tachycardias need to differentiate wide complex (ventricular tachycardia) and narrow complex (supraventricular tachycardia or SVT). Airway - child is grunting - immediate intervention. Airway - deteriorates after oral airway, next provide bag-mask ventilation. Airway - snoring with poor air entry bilaterally - reposition, oral airway.
    [Show full text]
  • Management of Wheeze and Cough in Infants and Pre-Schoo L Children In
    nPersonal opinio lManagement of wheeze and cough in infants and pre-schoo echildren in primary car Pauln Stephenso nIntroductio is, well established in adults 2thoughs there remain somer controversy about its diagnosis in children eve Managementa of wheeze and cough in children is sinceh Spelman's uncontrolled study of children wit commonm problem in primary care. In this paper I ai nchronic cough successfully treated according to a tod provide a few useful management tools with regar .asthma protocol 3gWithout the ability to perform lun toe diagnosis, the role of a trial of treatment, and th functione tests in pre-school children, care must b rationalee for referral. For an in-depth review see th takent to exclude other diagnoses. A persisten article. in this journal two years ago by Bush 1 eproductiv coughc may be due solely to chroni catarrhe with postnasal drip, but early referral may b sPresentation of Symptom needed. A persistent dry cough,n worse at night and o exercise,s and without evidence of other diagnose Ity is always worth asking parents what they mean b warrants. a trial of asthma treatment thed term 'wheeze' or 'cough'. The high-pitche musicaln noise of a wheeze usually on expiratio Thef younger the child, the longer the list o shouldy not be confused with the sound of inspirator differentialo diagnoses and the more one has t sstridor. The sound of airflow through secretions i econsider possibilities other than 'asthma'. Thes ddifferent again, and parents may describe their chil linclude upper airways disease, congenital structura 'vomiting'g when, in fact, the child has been coughin diseasel of the bronchi, bronchial or trachea severely and bringing up phlegm or mucus.
    [Show full text]
  • Gas Exchange and Respiratory Function
    LWBK330-4183G-c21_p484-516.qxd 23/07/2009 02:09 PM Page 484 Aptara Gas Exchange and 5 Respiratory Function Applying Concepts From NANDA, NIC, • Case Study and NOC A Patient With Impaired Cough Reflex Mrs. Lewis, age 77 years, is admitted to the hospital for left lower lobe pneumonia. Her vital signs are: Temp 100.6°F; HR 90 and regular; B/P: 142/74; Resp. 28. She has a weak cough, diminished breath sounds over the lower left lung field, and coarse rhonchi over the midtracheal area. She can expectorate some sputum, which is thick and grayish green. She has a history of stroke. Secondary to the stroke she has impaired gag and cough reflexes and mild weakness of her left side. She is allowed food and fluids because she can swallow safely if she uses the chin-tuck maneuver. Visit thePoint to view a concept map that illustrates the relationships that exist between the nursing diagnoses, interventions, and outcomes for the patient’s clinical problems. LWBK330-4183G-c21_p484-516.qxd 23/07/2009 02:09 PM Page 485 Aptara Nursing Classifications and Languages NANDA NIC NOC NURSING DIAGNOSES NURSING INTERVENTIONS NURSING OUTCOMES INEFFECTIVE AIRWAY CLEARANCE— RESPIRATORY MONITORING— Return to functional baseline sta- Inability to clear secretions or ob- Collection and analysis of patient tus, stabilization of, or structions from the respiratory data to ensure airway patency improvement in: tract to maintain a clear airway and adequate gas exchange RESPIRATORY STATUS: AIRWAY PATENCY—Extent to which the tracheobronchial passages remain open IMPAIRED GAS
    [Show full text]
  • Chief Compaint/HPI History
    PULMONOLOGY ASSOCIATES OF TEXAS 6860 North Dallas Pkwy, Ste 200, Plano, TX 75024 Tel: 469-305-7171 Fax: 469-212-1548 Patient Name: Thomas Cromwell Patient DOB: 02-09-1960 Patient Sex: Male Visit Date: 03-06-2016 Chief Compaint/HPI Chief Complaint: Shortness of Breath History of Present Illness: he patient is an 56-year-old male. From the last few days, he is not feeling well. Complains of fatigue, tiredness, weakness, nausea, no vomiting, no hematemesis or melena. The patient relates to have some low-grade fever. The patient came to the emergency room. Initially showed atrial fibrillation with rapid ventricular response. It appears that the patient has chronic atrial fibrillation. As per the medications, they are not very clear. He denies any specific chest pain. Her main complaint is shortness of breath and symptoms as above Pulmonary symptoms: cough, sputum, no hemoptysis, dyspnea and wheezing. History Past Medical History: Pulmonary history includes pneumonia and sleep apnea. Cardiac history includes atrial fibrillation and congestive heart failure. Remainder of PMH is non-significant. Surgical History: appendectomy in 2007. Medications: Pulmonary medications are albuterol and Spiriva; Cardiac medications include: atenolol and digoxin; Family History: Father is deceased at age 80. Father PMH remarkable for CHF, hypertension and MI; Mother is alive. Mother PMH remarkable for alzheimers, diabetes and hypertension; Cancer history in family: No Lung disease in the family: No Social History: Current every day smoker - 1 pack / day Alcohol consumption: social Marital status: lives alone Exposure History: Occupation: farmer. Asbestos exposure: None. No exposure to Ground Zero. Immunization History: Patient has an immunization history of flu shot, H1N1shot and pneumococcal shot.
    [Show full text]
  • Respiratory Failure Diagnosis Coding
    RESPIRATORY FAILURE DIAGNOSIS CODING Action Plans are designed to cover topic areas that impact coding, have been the frequent source of errors by coders and usually affect DRG assignments. They are meant to expand your learning, clinical and coding knowledge base. INTRODUCTION Please refer to the reading assignments below. You may wish to print this document. You can use your encoder to read the Coding Clinics and/or bookmark those you find helpful. Be sure to read all of the information provided in the links. You are required to take a quiz after reading the assigned documents, clinical information and the Coding Clinic information below. The quiz will test you on clinical information, coding scenarios and sequencing rules. Watch this video on basics of “What is respiration?” https://www.youtube.com/watch?v=hc1YtXc_84A (3:28) WHAT IS RESPIRATORY FAILURE? Acute respiratory failure (ARF) is a respiratory dysfunction resulting in abnormalities of tissue oxygenation or carbon dioxide elimination that is severe enough to threaten and impair vital organ functions. There are many causes of acute respiratory failure to include acute exacerbation of COPD, CHF, asthma, pneumonia, pneumothorax, pulmonary embolus, trauma to the chest, drug or alcohol overdose, myocardial infarction and neuromuscular disorders. The photo on the next page can be accessed at the link. This link also has complete information on respiratory failure. Please read the information contained on this website link by NIH. 1 http://www.nhlbi.nih.gov/health/health-topics/topics/rf/causes.html
    [Show full text]
  • Respiratory System Diseases & Disorders
    Respiratory System Diseases & Disorders HS1, DHO8, 7.10, pg 206 Objectives Discuss the diseases and disorders of the respiratory system and related signs, symptoms, and treatment methods Identify diseases and disorders that affect the respiratory system, including the following: asthma, pleurisy, bronchitis, pneumonia, COPD, rhinitis, emphysema, sinusitis, epistaxis, sleep apnea, influenza, TB, laryngitis, URI, and lung cancer Day 1 Respiratory Diseases and Disorders Upper Respiratory Tract The major passages and structures of the upper respiratory tract include the nose, nasal cavity, pharynx, and larynx. Asthma Bronchospasms with increase in mucous, and edema in mucosal lining Caused by sensitivity to allergen such as dust, pollen, animal, medications, or food Stress, overexertion, and infection can cause asthma attack Prevent asthma attacks by eliminating or desensitizing to allergens Symptoms: dyspnea, wheezing, coughing, and chest tightness Treatment: bronchodilators, anti-inflammatory med, epinephrine, and O2 therapy Test Your Knowledge Barbara has asthma and uses an inhaler when she starts to wheeze. The purpose of the device is to: a) Dissolve mucus b) Contract blood vessels c) Liquify secretions in the lungs d) Enlarge the bronchioles Correct answer: D Acute Bronchitis Chronic Bronchitis ◦ Caused by infection ◦ Caused by frequent attacks of ◦ S/S: productive cough, acute bronchitis or long-term exposure to smoking dyspnea, rales (bubbly breath sounds), chest ◦ Has chronic inflammation, pain, and fever damaged cilia, &
    [Show full text]
  • Bronchiectasis and Cystic Fibrosis
    Medical Services BRONCHIECTASIS AND CYSTIC FIBROSIS EBM – Bronchiectasis and Cystic Fibrosis Version: 2a (draft) MED/S2/CMEP~0053 (d) Page 1 Medical Services 1 Bronchiectasis 1.1 Description Bronchiectasis is a chronic disease characterised by irreversible dilatation of the bronchi due to bronchial wall damage from infection and inflammation. It is accompanied by chronic suppurative lung disease with productive cough and purulent sputum. The disease is caused by impairment of the mucociliary transport system, which normally protects the lungs from infection. This predisposes the lungs to bacterial infection, and hence an inflammatory response, increased mucus production and further impairment of mucociliary function. The walls of the bronchi become infiltrated by inflammatory tissue, losing their elastin content to become thin and dilated. 1.2 Aetiology Respiratory Infections cause the majority of cases. a) Infective and Aspiration Pneumonias (70% are bacterial and 30% are viral.) b) Tuberculosis (TB) (common in developing countries with increasing incidence in the UK.) c) Childhood Pertussis and Measles. Cystic Fibrosis – see Part 2. Bronchial Obstruction. a) Inhaled Foreign Body e.g. peanut. b) Bronchial Carcinoma. c) Lymph Node Enlargement e.g. TB. Immune Deficiency. a) HIV infection and AIDS.[1] b) Haematological Malignancies. c) Hypogammaglobulinaemia. Smoking (Impairs lung function and accelerates the progression of bronchiectasis.) [1] Allergic Bronchopulmonary Aspergillosis. Other Rare Causes. a) Inherited Ciliary Dyskinesias e.g. Kartagener’s Syndrome. b) Autoimmune Diseases e.g. ulcerative colitis, rheumatoid arthritis, vasculitis. Rarely, the cause of bronchiectasis cannot be determined. EBM – Bronchiectasis and Cystic Fibrosis Version: 2a (draft) MED/S2/CMEP~0053 (d) Page 2 Medical Services 1.3 Prevalence During the 20th century, severe and chronic respiratory infections declined in frequency due to the introduction of childhood vaccinations, the development of antibiotics, and improvements in socio-economic conditions.
    [Show full text]
  • Peri-Operative Respiratory Complications and the Post-Operative Consequences – Atelectasis and Risk Factors
    Pelosi_edit_Layout 1 13/01/2010 10:15 Page 17 Respiratory and Airway Management Peri-operative Respiratory Complications and the Post-operative Consequences – Atelectasis and Risk Factors Paolo Pelosi1 and Cesare Gregoretti2 1. Associate Professor, Department of Environment, Health and Safety, University of Insubria, Varese; 2. Director, Anaesthesia and Intensive Care Services, Maria Adelaide Hospital, Turin Abstract Post-operative pulmonary complications (PPCs) play a significant role in the risks of surgery and anaesthesia. The definition of PPCs is not definitely established and may vary between different studies. Potential patient-related risk factors for PPCs are: age; chronic lung disease; cigarette use; congestive heart failure; functional dependence; American Society of Anesthesiologists (ASA) classification; obesity; asthma; obstructive sleep apnoea; impaired sensorium, abnormal findings on chest examination, alcohol use and weight loss; and exercise capacity, diabetes and HIV infection. Risk factors not related to the patient’s clinical characteristics are surgical site, duration of surgery, anaesthetic technique and emergency surgery. The most important and morbid PPCs are atelectasis, pneumonia and respiratory failure, which contribute to increased morbidity, mortality and hospital length of stay. An appropriate ventilation setting during mechanical ventilation for general anaesthesia may reduce intra-operative atelectasis, with beneficial effects in the post-operative period. Lung expansion modalities, mainly physiotherapy
    [Show full text]